stockmarketproxy
/
IDXXNasdaq SEC EDGAR

IDEXX LABORATORIES INC /DE

In Vitro & In Vivo Diagnostic Substances·WESTBROOK, ME·FY end 12/31·CIK 874716
OverviewFinancialsCompensationGovernanceInsidersFilings

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Jonathan J. MazelskyPresident and Chief Executive Officer
$1.1M$5.4M$5.4M$2.6M$37.2K$14.6M
Michael J. LaneExecutive Vice President and General Manager, CAG Diagnostics Business Unit
$594.1K$1.3M$1.3M$627.3K$98.3K$4.0M
Tina HuntPhD Executive Vice President, Global Strategy and Commercial
$594.1K$1.3M$1.3M$627.3K$24.2K$3.9M

CEO pay mix

Jonathan J. Mazelsky · FY 2025
Total$14.6M
Stock awards$5.4M37%
Performance bonus$2.6M18%
Salary$1.1M8%
Other$5.4M37%

Performance vs. pay

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure
FY
TSR
CEO comp
FY21
+32%
$28M
FY22
-18%
$-14M
FY23
+11%
$23M
FY24
-17%
$2M
FY25
+35%
$32M

CEO comp · median worker · ratio — multi-year trend

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.